DailyClout
0
  • Home
  • Billcam
  • Campaigns
  • Submissions
  • Events
  • Shop
  • Donate
  • Become a Member!
  • Login/Sign Up
  • Home
  • Billcam
  • Campaigns
  • Submissions
  • Events
  • Shop
  • Donate
  • Become a Member!
  • Login/Sign Up
  • All Posts
  • Bulletin Board
  • Opinion
  • Pfizer Analysis
  • Hot Bills
  • Videos
  • Dr. Naomi Wolf’s Outspoken
  • The Mindful Activist
  • Sponsored Content
  • Press Releases
  • Contributors

DailyClout Pfizer Documents Analysis

Comparisons Between Pfizer’s EUA, Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, and New Studies Raises Several New Questions

March 17, 2022 • by Zoe Wilson
There was a recent study that was published on January 25, 2022 with data compiled from December 2020 through August 2021.
https://jamanetwork.com/journals/jama/fullarticle/2788346
There is a cross over in timeline between that new study and Pfizer’s Cumulative Analysis of Post-Authorization Adverse Event Reports, document 5.3.6.
https://phmpt.org/wp-content/uploads/2021/11/5.3.6-postmarketing-experience.pdf
Document 5.3.6 contains data from December 2020 to February 2021. This recent study has been showing a much higher risk of myocarditis than what was presented in document 5.3.6.
If you go to table 2 of the January 25, 2022 study, found in the third tab up at the top of the study linked above, you can see what I am about to refer to. Expected cases of myocarditis in male children aged 12-15 was 0.53 per million doses. Reported cases on VAERS after a second dose in that age group was 70.73 per million doses. That is 133x more than what was expected.
Children aged 16-17 is a comparison we can make between the January 25, 2022 study and the Pfizer data, but we need to keep in mind that document 5.3.6 groups everyone ages 16+ together and did not mention any specific age brackets. On that same table from the January 25, 2022 study, you can see that expected cases of myocarditis for males aged 16-17 was 1.34 per million doses, but the reported cases on VAERS after a second dose was 105.86 per million. That is 79x more than what was expected.
Going back to document 5.3.6, if you go to page 16, you can see where they have listed cardiovascular AESIs. Out of the 1,403 cases we have 41 cases of myocardial infraction and their conclusion is that it “does not raise any new safety issues” and that “surveillance will continue.”
Now that there is new information available, how are there no changes in policy towards vaccinating children when there are statistics showing that cases of myocarditis is 133x and 79x more than what was expected? Surely this would qualify as a “new safety issue.”
If this is not new information, like document 5.3.6 states, why does Pfizer’s EUA Memorandum not reflect this information? This is incredibly strange. There appears to be several inconsistencies and there are several things that are not adding up between all of the documents that are now available to us.
Spread the love
Zoe Wilson

Zoe Wilson is a licensed New York State attorney. General practice, with a focus in Immigration Law, specifically asylum seekers.

Spread the love
Spread the love
pfizer analysis pfizer campaign Pfizer documents
Previous StoryDr Robert Malone and Dr Ryan Cole React to CDC Hiding Data
Next StoryRepublican Majority Defending Rights and Freedom in New Hampshire

Leave your comment Cancel Reply

(will not be shared)

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Recent Posts

  • hives
    Report 65: In the First Three Months of Pfizer’s mRNA “Vaccine” Rollout, Nine Patients Died of Anaphylaxis. 79% of Anaphylaxis Adverse Events Were Rated as “Serious.” Friday, 31, Mar
  • 719a86b8-1d55-4208-adc7-9c261455db55
    This is The New Beginning of Real Medicine Friday, 31, Mar
  • Trump Indictment Spurs Glenn Beck to Wholeheartedly Support the Former President on Tucker Carlson Tonight
    Trump Indictment Spurs Glenn Beck to Wholeheartedly Support the Former President on Tucker Carlson Tonight Friday, 31, Mar
  • Screenshot 2023-03-29 8.51.38 PM
    MAKING HISTORY: The WarRoom/DailyClout Pfizer Docs Analysis Reports Thursday, 30, Mar
  • pexels-liza-summer-6382660
    3 Things You Need to Know About Treating Spike & Post-COVID Syndrome Thursday, 30, Mar

Blog Archive

Subscribe to Our Newsletter

  • I agree to receive emails and other content from DailyClout. I understand that I may repeal my consent at any time.

  • Home
  • Contact Us
  • BillCam
  • Campaigns
  • About Us
  • Submissions
  • Advertise with Us
  • Events
  • Media Contact
View Cart Checkout
Do you really want to logout of DailyClout?
Yes

You are now leaving DailyClout...